Skip to main content
Figure 1 | BMC Gastroenterology

Figure 1

From: Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis

Figure 1

Kaplan-Meier curves for OS of the RT (bold lines) and sorafenib (solid lines) groups. (a), all patients (n = 97) and (b), PS-matched patients (n = 56). Although no significant difference between the two groups is observed in (a) (P = 0.115), OS in the PS-matched patients is significantly longer in the RT group (median 10.9 months) than in the sorafenib group (median 4.8 months), as shown in (b) (P = 0.002, log-rank test).

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us